← Leaderboards
Ann B. Nattinger
Medical College Of Wisconsin
$10,426,229
Attributed
$13,122,615
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,122,615 · 7
By mechanism
R01$13,122,615 · 7
Top collaborators
- Liliana E. Pezzin11 shared
Most similar at Medical College Of Wisconsin
Same institution · by research overlap
- Stephen A Boppart$30,859,533
- Liliana E. Pezzin$4,020,428
- Kirsten M Beyer$2,466,400
- Joan Marie Neuner$5,454,746
- Jennifer Mary Knight$1,505,010
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanMalignant Breast NeoplasmInterestBaseMedicareOperative Surgical ProceduresMalignant NeoplasmsCaringCohortCharacteristicsCessation Of LifeHormone TherapyAdjuvantPostmenopauseCancer CareProgramsInnovationMedicalPoliciesEffectivenessHospitalsExhibitsLow Socioeconomic StatusBreast Cancer Patient
Grant awards (31)
A longitudinal, nationally representative study of cognition-related effects of breast cancer and its treatment$356,850
R01 · FY2025 · CA · contact PI
A longitudinal, nationally representative study of cognition-related effects of breast cancer and its treatment$339,008
R01 · FY2024 · CA · contact PI
A longitudinal, nationally representative study of cognition-related effects of breast cancer and its treatment$349,713
R01 · FY2023 · CA · contact PI
A longitudinal, nationally representative study of cognition-related effects of breast cancer and its treatment$356,850
R01 · FY2022 · CA · contact PI
Can regionalization improve outcomes and reduce disparities related to breast cancer care? An Evaluation of the NY Medicaid regionalization experiment$357,843
R01 · FY2021 · CA · contact PI
Can regionalization improve outcomes and reduce disparities related to breast cancer care? An Evaluation of the NY Medicaid regionalization experiment$357,843
R01 · FY2020 · CA · contact PI
Can regionalization improve outcomes and reduce disparities related to breast cancer care? An Evaluation of the NY Medicaid regionalization experiment$371,343
R01 · FY2019 · CA · contact PI
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care$617,350
R01 · FY2017 · CA · contact PI
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care$802,301
R01 · FY2016 · CA · contact PI
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care$680,845
R01 · FY2015 · CA · contact PI
Mechanisms Underlying SES Disparities in Breast Cancer Mortality$381,828
R01 · FY2015 · CA
(PQE3)A Statewide RCT to Reduce Use of Ineffective or Unproven Breast Cancer Care$729,945
R01 · FY2014 · CA · contact PI
Mechanisms Underlying SES Disparities in Breast Cancer Mortality$375,301
R01 · FY2014 · CA
Mechanisms Underlying SES Disparities in Breast Cancer Mortality$402,782
R01 · FY2013 · CA
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage$363,224
R01 · FY2013 · CA · contact PI
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage$468,564
R01 · FY2012 · CA · contact PI
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage$417,917
R01 · FY2011 · CA · contact PI
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage$538,061
R01 · FY2010 · CA · contact PI
SES Disparities in Breast Cancer: Effect of Pharmaceutical Coverage$600,133
R01 · FY2009 · CA · contact PI
Outcomes of Older Women with Early Stage Breast Cancer$395,102
R01 · FY2008 · CA · contact PI
Outcomes of Older Women with Early Stage Breast Cancer$454,562
R01 · FY2007 · CA · contact PI
Outcomes of Older Women with Early Stage Breast Cancer$459,600
R01 · FY2006 · CA · contact PI
Quality of Follow-up Care for Breast Cancer Survivors$293,316
R01 · FY2006 · CA · contact PI
Outcomes of Older Women with Early Stage Breast Cancer$464,324
R01 · FY2005 · CA
Quality of Follow-up Care for Breast Cancer Survivors$300,375
R01 · FY2005 · CA
Outcomes of Older Women with Early Stage Breast Cancer$525,767
R01 · FY2004 · CA
Quality of Follow-up Care for Breast Cancer Survivors$333,750
R01 · FY2004 · CA
Quality of Follow-up Care for Breast Cancer Survivors$327,075
R01 · FY2003 · CA
OUTCOMES OF OLDER WOMEN WITH EARLY STAGE BREAST CANCER$201,825
R01 · FY2002 · CA
OUTCOMES OF OLDER WOMEN WITH EARLY STAGE BREAST CANCER$201,825
R01 · FY2001 · CA
OUTCOMES OF OLDER WOMEN WITH EARLY STAGE BREAST CANCER$297,393
R01 · FY2000 · CA